154 related articles for article (PubMed ID: 32766147)
21. Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
Bokemeyer C; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Einhorn L; Nichols CR; Hartmann JT
Cancer; 2001 Apr; 91(7):1394-401. PubMed ID: 11283942
[TBL] [Abstract][Full Text] [Related]
22. Survival Outcomes of Patients With Mediastinal Germ Cell Tumors: Experience of a Cancer Center in South America.
Vallejo-Yepes C; Carvajal-Fierro CA; Brugés-Maya R; Beltrán J; Buitrago R; Beltrán-Jimenez R; Carreño-Dueñas JA
Front Oncol; 2021; 11():758496. PubMed ID: 35047390
[TBL] [Abstract][Full Text] [Related]
23. A single institution, retrospective study of treatment experience in primary mediastinal germ cell tumors: elucidating the significance of systemic chemotherapy.
Wang JL; Yu H; Guo Y; Hu XC; Pan ZQ; Chang JH; Zhang YW
Chin Med J (Engl); 2012 Feb; 125(4):626-30. PubMed ID: 22490486
[TBL] [Abstract][Full Text] [Related]
24. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
25. Primary mediastinal germ cell tumors.
Rosti G; Secondino S; Necchi A; Fornarini G; Pedrazzoli P
Semin Oncol; 2019 Apr; 46(2):107-111. PubMed ID: 31076171
[TBL] [Abstract][Full Text] [Related]
26. High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
Adra N; Abonour R; Althouse SK; Albany C; Hanna NH; Einhorn LH
J Clin Oncol; 2017 Apr; 35(10):1096-1102. PubMed ID: 27870561
[TBL] [Abstract][Full Text] [Related]
27. Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience.
Yaegashi H; Nohara T; Shigehara K; Izumi K; Kadono Y; Makino T; Yamashita K; Ohtsubo K; Ikeda H; Mizokami A
Cancer Diagn Progn; 2022; 2(3):352-359. PubMed ID: 35530648
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant radiotherapy in stage 1 seminoma: Evaluation of prognostic factors and results of survival.
Serdar L; Canyilmaz E; Topcu TO; Sahbaz A; Memis Y; Soydemir G; Aynaci O; Kandaz M; Bahat Z; Yoney A
J Cancer Res Ther; 2015; 11(2):313-8. PubMed ID: 26148592
[TBL] [Abstract][Full Text] [Related]
29. [Bilateral germ cell testicular tumors].
Géczi L; Gomez F; Bak M; Bodrogi I
Magy Onkol; 2001; 45(5):417-423. PubMed ID: 12050690
[TBL] [Abstract][Full Text] [Related]
30. [Adjuvant treatment for stage I of testicular germ cell tumours].
Lakomý R; Poprach A; Nēmecek R; Vyskocil J; Ondrová B; Kocák I; Kocáková I; Rehák Z; Vyzula R
Klin Onkol; 2009; 22(1):22-6. PubMed ID: 19534436
[TBL] [Abstract][Full Text] [Related]
31. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
[TBL] [Abstract][Full Text] [Related]
32. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.
Hallemeier CL; Pisansky TM; Davis BJ; Choo R
Urol Oncol; 2013 Nov; 31(8):1832-8. PubMed ID: 22537538
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors and outcomes of nonseminomatous germ cell tumours of testis-experience from a tertiary cancer centre in India.
Nair LM; Krishna KMJ; Kumar A; Mathews S; Joseph J; James FV
Ecancermedicalscience; 2020; 14():1145. PubMed ID: 33343704
[TBL] [Abstract][Full Text] [Related]
35. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
[TBL] [Abstract][Full Text] [Related]
36. Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
Bokemeyer C; Hartmann JT; Fossa SD; Droz JP; Schmol HJ; Horwich A; Gerl A; Beyer J; Pont J; Kanz L; Nichols CR; Einhorn L
APMIS; 2003 Jan; 111(1):49-59; discussion 59-63. PubMed ID: 12752235
[TBL] [Abstract][Full Text] [Related]
37. [Expression of CD117 in human testicular germ cell tumors and its diagnostic value for seminoma and nonseminoma].
Liu DL; Lu YP; Shi HY; Zhu SX; Lü JW; Li WF; Rong X
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):38-41. PubMed ID: 18297810
[TBL] [Abstract][Full Text] [Related]
38. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of pediatric and adolescent mediastinal germ cell tumors: a single pediatric oncology institutional experience.
Grabski DF; Pappo AS; Krasin MJ; Davidoff AM; Rao BN; Fernandez-Pineda I
Pediatr Surg Int; 2017 Feb; 33(2):235-244. PubMed ID: 27838767
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.
Adra N; Althouse SK; Liu H; Brames MJ; Hanna NH; Einhorn LH; Albany C
Ann Oncol; 2016 May; 27(5):875-9. PubMed ID: 26861605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
